EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

M1 Macrophage Extracellular Vesicles and TLR3 Agonist Nanoparticles Down‐Regulate Immunosuppression and Metastasis via AKT/TAM in Triple‐Negative Breast Cancer

Shirley V de Paiva Souza, Andreza Conceição Veras Aguiar, Elizabeth Costa S de Albuquerque, Christina Eich, Luis J Cruz, Pablo Lara, Carla Jorquera-Cordero, Raelle Ferreira Gomes, Regina Célia Monteiro de Paula, Rosemayre S Freire, de Araújo Júnior Raimundo Fernandes de AraújoJúnior

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.70003 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2025. Written by Shirley V de Paiva Souza and 10 co-authors. Institution: Postgraduate Program in Health Science, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil. Major MEDLINE topics: Triple Negative Breast Neoplasms, Toll-Like Receptor 3, Nanoparticles, Macrophages. Cited 9 times so far (Crossref); 76 references. The full text is freely available (open access, CC BY 4.0). Funded by: I would like to thank CAPES for supporting this study through the scholarship 88887.906999/2023-00 and CNPq by financial support (303750/2023-5)..

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Metastasis induced by tumor immune escape has been implicated as one of the factors contributing to the aggressiveness of triple‐negative breast cancer. Macrophage type 1‐derived extracellular vesicles were isolated and combined with PLGA nanoparticles loaded with the TLR3 agonist poly I:C as a therapeutic strategy to investigate their antitumor activity by downregulating tumor immune escape in the tumor microenvironment (TME) of breast cancer in a murine model of orthotopic tumor growth. Tumors were evaluated by qRT‐PCR and immunohistochemistry. Cellular uptake and polarization of murine macrophages (RAW 264.7 cells) were analyzed In Vitro by immunofluorescence and flow cytometry, respectively. Furthermore, mouse survival, lymph node involvement, and metastasis were also evaluated. In the animal model, the combination therapy inhibited tumor progression through TME immunomodulation, leading to a reduction in primary tumor size ( p < 0.0001) and metastasis, along with an extension in survival of 11 days. Importantly, both innate and adaptive immune responses were enhanced, as indicated by increased CD8 expression ( p < 0.0001) and reduced PD‐L1 levels in the TME, as well as elevated CD11c expression in lymph nodes ( p < 0.0001). Likewise, the combination therapy suppressed tumor progression by reducing AKT1 expression ( p < 0.001) and increasing E‐cadherin expression ( p < 0.01). Based on these findings, the combination therapy functioned as a “vaccine‐like immunomodulatory strategy,” promoting TME immunomodulation and suppressing metastasis in a murine model of triple‐negative breast cancer.

Subjects

MeSH terms (MEDLINE)

Triple Negative Breast NeoplasmsToll-Like Receptor 3NanoparticlesMacrophagesProto-Oncogene Proteins c-aktExtracellular VesiclesPoly I-CAnimalsFemaleMiceTumor MicroenvironmentHumansRAW 264.7 CellsCell Line, Tumor

Author keywords

TLR agoniztsexosomesimmunotherapynanomedicinetargeted immune response

Substances

Toll-Like Receptor 3Proto-Oncogene Proteins c-aktPoly I-C

Authors and institutions

  • Postgraduate Program in Health Science, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.
  • Inflammation and Cancer Research Laboratory, Department of Morphology, Federal University of Rio Grande do Norte (UFRN), Natal, Brazil.
  • Translational Nanobiomaterials and Imaging (TNI) Group, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Orthopedics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Organic and Inorganic Chemistry, Federal University of Ceará, UFC, Fortaleza, Brazil.
  • Department of Physics, Federal University of Ceará, Fortaleza, Brazil.

Funding

  • I would like to thank CAPES for supporting this study through the scholarship 88887.906999/2023-00 and CNPq by financial support (303750/2023-5).

Cite

APA

Souza, S. V. P., Aguiar, A. C. V., Albuquerque, E. C. S., Eich, C., Cruz, L. J., Lara, P., Jorquera-Cordero, C., Gomes, R. F., Paula, R. C. M., Freire, R. S., & de AraújoJúnior, A. J. R. F. (2025). M1 Macrophage Extracellular Vesicles and TLR3 Agonist Nanoparticles Down‐Regulate Immunosuppression and Metastasis via AKT/TAM in Triple‐Negative Breast Cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70003

Vancouver

Souza SVP, Aguiar ACV, Albuquerque ECS, Eich C, Cruz LJ, Lara P, et al. M1 Macrophage Extracellular Vesicles and TLR3 Agonist Nanoparticles Down‐Regulate Immunosuppression and Metastasis via AKT/TAM in Triple‐Negative Breast Cancer. Molecular Carcinogenesis. 2025. doi:10.1002/mc.70003

BibTeX
@article{Souza2025,
  author = {Souza, Shirley V de Paiva and Aguiar, Andreza Conceição Veras and Albuquerque, Elizabeth Costa S de and Eich, Christina and Cruz, Luis J and Lara, Pablo and Jorquera-Cordero, Carla and Gomes, Raelle Ferreira and Paula, Regina Célia Monteiro de and Freire, Rosemayre S and de AraújoJúnior, de Araújo Júnior Raimundo Fernandes},
  title = {M1 Macrophage Extracellular Vesicles and TLR3 Agonist Nanoparticles Down‐Regulate Immunosuppression and Metastasis via AKT/TAM in Triple‐Negative Breast Cancer},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.70003}
}
Start for free →